The latest addition to the range, Aixplorer MACH 20 benefits from the new generation of UltraFastTM imaging with an exceptional image quality to address challenges encountered in daily practice. Aixplorer MACH 20 gives radiologists access to an imaging mode developed by SuperSonic Imagine: ShearWave PLUS, the only technique that can visualise, analyse and quantify tissue hardness in real time. ShearWave PLUS has changed the paradigm of ultrasound practice and has become a standard in non-invasive care in the detection of breast and liver lesions.
A symposium on “The latest innovations in UltraFast ultrasound imaging - new ultrasound markers for the liver and the breast”
Saturday, October 12 from 1 pm to 2 pm (Room 241)
Dr F. Chamming, radiologist (Bordeaux, France) will speak about new advances in breast ultrasound imaging using ShearWave elastography - now and in the future - and Professor Vilgrain, radiologist (Paris, France), will present the quantitative multiparametric ultrasound technology for the evaluation of chronic liver diseases.
SuperSonic Imagine will also be present at the “Ultrasound Village”, an area dedicated to ultrasound technology for experienced as well as younger radiologists, to present and give the opportunity to test its latest innovations.
Model demonstrations will be held throughout the JFR congress at the SuperSonic Imagine booth (no. 217, level 2), at the Ultrasound Village and in a number of ultrasound-focused workshops.
Earlier this year, Hologic, Inc. (Nasdaq : HOLX), a global leader in women’s health, announced its intent to acquire SuperSonic Imagine and has acquired approximately 46% of SuperSonic Imagine shares, pursuant to a shares sale agreement.
About SuperSonic Imagine
SuperSonic Imagine specializes in ultrasound medical imaging. The company manufactures the flagship Aixplorer® series of products, which feature the company’s exclusive UltraFast™ technology. UltraFast™ has given rise to new imaging modes that set the standards of care for non-invasive characterization of breast, liver and prostate diseases. The first groundbreaking UltraFast™ mode developed is ShearWave™ Elastography (SWE™), which enables doctors to view and instantly analyze tissue stiffness, a vitally important factor in the diagnosis of many conditions. To date, more than 600 published articles have validated the diagnostic value of SWE. Aixplorer MACH® 30 ultrasound platform that introduces the next generation of UltraFast™ imaging, which optimizes the system’s innovative imaging modes: ShearWave PLUS, Doppler UltraFast™, Angio PL.U.S, TriVu and Needle PL.U.S. The company has more than 2,300 ultrasound systems installed in over 80 countries. Its main growth markets are China, the United States and the European Union (France). In 2018, the company generated a turnover of €24.6 million in 2018. SuperSonic Imagine is a company listed on Euronext (symbol: SSI).
Back to HCB News
